The field of ophthalmic regenerative medicine is poised for significant growth, driven by the increasing prevalence of eye diseases. According to a recent analysis, the Birth Tissue Products Market for these innovative treatments is expected to climb at a robust Compound Annual Growth Rate (CAGR) of 6.6% from 2023 to 2033. This surge aligns with …